세계의 분자 파밍 시장 : 제품 유형별, 식물 유형별, 용도별, 최종 사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Molecular Pharming Market size was valued at US$ 1,787.24 Million in 2024, expanding at a CAGR of 8.5% from 2025 to 2032.

The Molecular Pharming Market involves the use of genetically modified plants to produce pharmaceutical substances such as vaccines, antibodies, enzymes, and therapeutic proteins. This innovative bioEnd-user process transforms plants into biofactories by inserting specific genes that encode the desired therapeutic proteins. Molecular pharming offers a cost-effective, scalable, and safer alternative to traditional cell-based or microbial fermentation methods. It eliminates the risk of contamination from human pathogens and can be rapidly deployed during health crises.

Crops like tobacco, maize, and rice are commonly used due to their fast growth and ease of genetic manipulation. The End-user has gained attention for its potential to revolutionize vaccine production, especially in low-resource settings. Regulatory frameworks are evolving to address safety and efficacy concerns, helping accelerate market adoption. Demand is rising with increased investment in biotech R&D, especially for infectious diseases, cancer, and rare disorders.

Molecular Pharming Market- Market Dynamics

Rising demand for plant-based vaccines in low-resource and pandemic scenarios.

A key niche driver for the molecular pharming market is the rising demand for plant-based vaccines, especially in low-resource settings and during pandemic scenarios. Traditional vaccine production methods often rely on expensive infrastructure, cold chains, and long manufacturing timelines, making them less accessible in developing regions. Molecular pharming offers a solution by enabling rapid, scalable, and cost-effective production using plants, which can be grown locally with minimal resources.

This approach is particularly valuable during global health emergencies when speed and scalability are critical. Plant-based systems also reduce the risk of contamination with animal or human pathogens. Furthermore, advances in genetic engineering have enhanced the precision and efficiency of plant-based vaccine development. The ability to produce oral or edible vaccines also opens up new delivery methods that are easier to distribute. This growing interest supports molecular pharming as a strategic tool for equitable global healthcare.

Molecular Pharming Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2025-2032)

Based on product type segmentation, vaccines were predicted to show maximum market share in the year 2024

Based on Plant Type segmentation, tobacco was the leading Plant Type in 2024

Based on Application segmentation, Infectious Diseases were the leading Application in 2024

Based on End-User segmentation, Pharmaceutical Companies were the leading Application in 2024

Based on region, North America was the leading revenue generator in 2024

Molecular Pharming Market- Segmentation Analysis:

The Global Molecular Pharming Market is segmented on the basis of Product Type, Plant Type, Application, End-user, and Region.

The market is divided into three categories based on product type: Vaccines, Monoclonal Antibodies, Therapeutic Proteins, Enzymes, and Diagnostic Proteins. The most dominant segment in the molecular pharming market by product type is vaccines. Vaccines produced through molecular pharming have gained significant traction due to their potential for rapid, large-scale, and cost-effective production compared to traditional methods. Plant-based vaccines can be developed faster, which is crucial during outbreaks and pandemics where time is critical. Additionally, molecular pharming allows for the production of safer vaccines, as plants do not carry human pathogens, reducing contamination risks.

This segment benefits from growing global demand for affordable vaccines, especially in developing countries where traditional vaccine manufacturing infrastructure is limited. Advances in genetic engineering have improved vaccine efficacy and stability in plant systems. The increasing focus on infectious diseases, such as influenza, COVID-19, and other viral infections, further drives growth in this segment. Furthermore, regulatory agencies are gradually developing clearer frameworks for plant-derived vaccines, supporting market expansion. Overall, vaccines remain the leading product type, fueling the growth and innovation within the molecular pharming market.

The market is divided into four categories based on Plant Type: Tobacco, Maize (Corn), Rice, Potato, Algae, and Others. The tobacco segment is the most dominant in the molecular pharming market by plant type. Tobacco plants are preferred due to their fast growth rate, high biomass yield, and well-established genetic modification techniques. Unlike food crops, tobacco is not used for human consumption, which minimizes concerns about cross-contamination in the food supply chain. Its leaves provide an ideal platform for producing large quantities of pharmaceutical proteins, including vaccines and monoclonal antibodies.

Additionally, tobacco's ability to be grown in controlled environments such as greenhouses allows for consistent and scalable production. Many leading biotech companies have leveraged tobacco plants for rapid response during health emergencies, including producing antibodies for infectious diseases. The extensive research and infrastructure around tobacco as a host plant give it a competitive advantage over other plant types. As a result, tobacco continues to be the preferred choice for molecular pharming Plant Types, driving significant market growth.

Molecular Pharming Market- Geographical Insights

North America leads the global molecular pharming market, driven by its advanced infrastructure, substantial R&D investments, and a supportive regulatory environment. The United States, in particular, hosts numerous biotech firms and research institutions that are pioneering plant-based pharmaceutical production. This region benefits from a robust healthcare system, high healthcare expenditures, and favorable reimbursement policies, facilitating the adoption of innovative therapies. Collaborations between industry leaders, academic institutions, and government agencies have accelerated the development of molecular pharming technologies.

The United States stands at the forefront of the molecular pharming market, driven by a confluence of robust infrastructure, substantial R&D investments, and a supportive regulatory environment. The nation's advanced bioEnd-user sector is characterized by cutting-edge research institutions, well-established laboratories, and a comprehensive supply chain network, facilitating the efficient development and Application of molecular pharming products. Government initiatives play a pivotal role, offering financial incentives and fostering collaborations between industry, academia, and research institutions, thereby accelerating innovation and commercialization.

Molecular Pharming Market- Competitive Landscape:

The molecular pharming market features a competitive landscape dominated by key players such as Kentucky Bioprocessing, Medicago, iBio, Ventria Bioscience, and Protalix BioTherapeutics. These companies focus heavily on innovation to improve protein expression and production efficiency in plants. Strategic partnerships with academic institutions and government bodies are common, helping to accelerate R&D and regulatory approvals. Intellectual property protection is a critical factor, with many players securing patents to maintain their competitive edge.

Investments in advanced cultivation technologies, including controlled environment agriculture and bioreactors, are increasing to ensure consistent quality and scalability. Additionally, companies differentiate themselves by targeting specific therapeutic areas like vaccines and monoclonal antibodies. Navigating complex regulatory frameworks remains a challenge but also a barrier to entry, allowing established players to strengthen their positions. Overall, the competition drives technological progress and wider adoption of molecular pharming solutions.

Recent Developments:

In October 2024, Moolec Science obtained U.S. regulatory approval for genetically engineered peas (PEEA1) that produce iron-rich bovine myoglobin, offering a plant-based source of iron for consumers.

In February 2024, New Zealand-based food tech startup Miruku raised $5 million in a pre-Series A financing round to expand its molecular farming platform aimed at producing dairy proteins and fats.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MOLECULAR PHARMING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Kentucky Bioprocessing
• Medicago
• iBio
• Ventria Bioscience
• Protalix BioTherapeutics
• PlantForm Corporation
• Caliber Biotherapeutics
• Fraunhofer USA
• Icon Genetics
• Greenovation Biotech
• Dow AgroSciences
• Zymeworks
• Bayer CropScience
• Cibus
• PlantVax Inc.
• AquaBounty Technologies
• Phyton Biotech
• Vaxess Technologies
• Medicago Inc.
• PlantForm Corp.

GLOBAL MOLECULAR PHARMING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

• Vaccines
• Monoclonal Antibodies
• Therapeutic Proteins
• Enzymes
• Diagnostic Proteins

GLOBAL MOLECULAR PHARMING MARKET, BY PLANT TYPE- MARKET ANALYSIS, 2019 - 2032

• Tobacco
• Maize (Corn)
• Rice
• Potato
• Algae
• Others

GLOBAL MOLECULAR PHARMING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Infectious Diseases
• Cancer
• Rare Diseases
• Autoimmune Disorders
• Others

GLOBAL MOLECULAR PHARMING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

• Pharmaceutical Companies
• Biotechnology Companies
• Research Institutes
• Contract Research Organizations (CROs)

GLOBAL MOLECULAR PHARMING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Molecular Pharming Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Molecular Pharming Market Snippet by Product Type
  • 2.1.2. Molecular Pharming Market Snippet by Plant Type
  • 2.1.3. Molecular Pharming Market Snippet by Application
  • 2.1.4. Molecular Pharming Market Snippet by End-user
  • 2.1.5. Molecular Pharming Market Snippet by Country
  • 2.1.6. Molecular Pharming Market Snippet by Region
• 2.2. Competitive Insights

3. Molecular Pharming Key Market Trends

• 3.1. Molecular Pharming Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Molecular Pharming Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Molecular Pharming Market Opportunities
• 3.4. Molecular Pharming Market Future Trends

4. Molecular Pharming Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Molecular Pharming Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. Molecular Pharming Market Landscape

• 6.1. Molecular Pharming Market Share Analysis, 2024
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Molecular Pharming Market - By Product Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
  • 7.1.2. Vaccines
  • 7.1.3. Monoclonal Antibodies
  • 7.1.4. Therapeutic Proteins
  • 7.1.5. Enzymes
  • 7.1.6. Diagnostic Proteins

8. Molecular Pharming Market - By Plant Type

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Plant Type, 2024 & 2032 (%)
  • 8.1.2. Tobacco
  • 8.1.3. Maize (Corn)
  • 8.1.4. Rice
  • 8.1.5. Potato
  • 8.1.6. Algae
  • 8.1.7. Others

9. Molecular Pharming Market - By Application

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
  • 9.1.2. Infectious Diseases
  • 9.1.3. Cancer
  • 9.1.4. Rare Diseases
  • 9.1.5. Autoimmune Disorders
  • 9.1.6. Others

10. Molecular Pharming Market - By End-user

• 10.1. Overview
  • 10.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
  • 10.1.2. Pharmaceutical Companies
  • 10.1.3. Biotechnology Companies
  • 10.1.4. Research Institutes
  • 10.1.5. Contract Research Organizations (CROs)

11. Molecular Pharming Market- By Geography

• 11.1. Introduction
  • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
• 11.2. North America
  • 11.2.1. Overview
  • 11.2.2. Molecular Pharming Key Manufacturers in North America
  • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 11.2.5. North America Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
  • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.2.7. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.2.8. U.S.
    • 11.2.8.1. Overview
    • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.8.4. U.S. Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.8.6. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.2.9. Canada
    • 11.2.9.1. Overview
    • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.9.4. Canada Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.9.6. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
• 11.3. Europe
  • 11.3.1. Overview
  • 11.3.2. Molecular Pharming Key Manufacturers in Europe
  • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 11.3.5. Europe Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
  • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3.7. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.3.8. Germany
    • 11.3.8.1. Overview
    • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.8.4. Germany Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.8.6. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.3.9. UK
    • 11.3.9.1. Overview
    • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.9.4. UK Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.9.6. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.3.10. France
    • 11.3.10.1. Overview
    • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.10.4. France Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.10.6. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.3.11. Italy
    • 11.3.11.1. Overview
    • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.11.4. Italy Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.11.6. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.3.12. Spain
    • 11.3.12.1. Overview
    • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.12.4. Spain Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.12.6. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.3.13. The Netherlands
    • 11.3.13.1. Overview
    • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.13.4. The Netherlands Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.13.6. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.3.14. Sweden
    • 11.3.14.1. Overview
    • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.14.4. Sweden Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.14.6. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.3.15. Russia
    • 11.3.15.1. Overview
    • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.15.4. Russia Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.15.6. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.3.16. Poland
    • 11.3.16.1. Overview
    • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.16.4. Poland Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.16.6. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.3.17. Rest of Europe
    • 11.3.17.1. Overview
    • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
• 11.4. Asia Pacific (APAC)
  • 11.4.1. Overview
  • 11.4.2. Molecular Pharming Key Manufacturers in Asia Pacific
  • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 11.4.5. APAC Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
  • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4.7. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.4.8. China
    • 11.4.8.1. Overview
    • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.8.4. China Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.8.6. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.4.9. India
    • 11.4.9.1. Overview
    • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.9.4. India Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.9.6. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.4.10. Japan
    • 11.4.10.1. Overview
    • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.10.4. Japan Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.10.6. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.4.11. South Korea
    • 11.4.11.1. Overview
    • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.11.4. South Korea Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.11.6. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.4.12. Australia
    • 11.4.12.1. Overview
    • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.12.4. Australia Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.12.6. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.4.13. Indonesia
    • 11.4.13.1. Overview
    • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.13.4. Indonesia Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.13.6. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.4.14. Thailand
    • 11.4.14.1. Overview
    • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.14.4. Thailand Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.14.6. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.4.15. Philippines
    • 11.4.15.1. Overview
    • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.15.4. Philippines Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.15.6. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.4.16. Rest of APAC
    • 11.4.16.1. Overview
    • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.16.4. Rest of APAC Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
• 11.5. Latin America (LATAM)
  • 11.5.1. Overview
  • 11.5.2. Molecular Pharming Key Manufacturers in Latin America
  • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 11.5.5. LATAM Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
  • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.5.7. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.5.8. Brazil
    • 11.5.8.1. Overview
    • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.8.4. Brazil Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.8.6. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.5.9. Mexico
    • 11.5.9.1. Overview
    • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.9.4. Mexico Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.9.6. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.5.10. Argentina
    • 11.5.10.1. Overview
    • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.10.4. Argentina Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.10.6. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.5.11. Colombia
    • 11.5.11.1. Overview
    • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.11.4. Colombia Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.11.6. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.5.12. Rest of LATAM
    • 11.5.12.1. Overview
    • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
• 11.6. Middle East and Africa (MEA)
  • 11.6.1. Overview
  • 11.6.2. Molecular Pharming Key Manufacturers in Middle East and Africa
  • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 11.6.5. MEA Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
  • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6.7. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.6.8. Saudi Arabia
    • 11.6.8.1. Overview
    • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.6.9. United Arab Emirates
    • 11.6.9.1. Overview
    • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.6.10. Israel
    • 11.6.10.1. Overview
    • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.10.4. Israel Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.10.6. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.6.11. Turkey
    • 11.6.11.1. Overview
    • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.11.4. Turkey Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.11.6. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.6.12. Algeria
    • 11.6.12.1. Overview
    • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.12.4. Algeria Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.12.6. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.6.13. Egypt
    • 11.6.13.1. Overview
    • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.13.4. Egypt Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.13.6. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.6.14. Rest of MEA
    • 11.6.14.1. Overview
    • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.14.4. Rest of MEA Market Size and Forecast, By Plant Type, 2019 - 2032 (US$ Million)
    • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Molecular Pharming Industry

• 12.1. Competitive Dashboard
  • 12.1.1. Competitive Benchmarking
  • 12.1.2. Competitive Positioning
• 12.2. Company Profiles
  • 12.2.1. Kentucky Bioprocessing
  • 12.2.2. Medicago
  • 12.2.3. iBio
  • 12.2.4. Ventria Bioscience
  • 12.2.5. Protalix BioTherapeutics
  • 12.2.6. PlantForm Corporation
  • 12.2.7. Caliber Biotherapeutics
  • 12.2.8. Fraunhofer USA
  • 12.2.9. Icon Genetics
  • 12.2.10. Greenovation Biotech
  • 12.2.11. Dow AgroSciences
  • 12.2.12. Zymeworks
  • 12.2.13. Bayer CropScience
  • 12.2.14. Cibus
  • 12.2.15. PlantVax Inc.
  • 12.2.16. AquaBounty Technologies
  • 12.2.17. Phyton Biotech
  • 12.2.18. Vaxess Technologies
  • 12.2.19. Medicago Inc.
  • 12.2.20. PlantForm Corp

13. 360 Degree AnalystView

14. Appendix

• 14.1. Research Methodology
• 14.2. References
• 14.3. Abbreviations
• 14.4. Disclaimer
• 14.5. Contact Us